Regeneration and tolerance factor: a correlate of human immunodeficiency virus-associated T-cell activation

Human immunodeficiency virus (HIV) infection causes extensive phenotypic alterations in lymphocytes. Cellular markers that are normally absent or expressed at low levels on quiescent cells are upregulated throughout the disease course. The transmembrane form of regeneration and tolerance factor (RTF) is expressed at negligible levels on resting T cells but is quickly upregulated fallowing in vitro stimulation and activation. Recently, we reported that expression of RTF was significantly higher in cells from EW-seropositive (HIV+) individuals than in cells from EW-seronegative (HIV+) individuals. Because T cells from HIV+ individuals express markers reflecting chronic activation, we hypothesized that these in vivo-activated cells would coexpress RTP. Flow cytometry was used to assess RTF expression on activated (CD38(+) and HLA-DR+) CD4(+) and CD8(+) T cells. HIV+ individuals had higher percentages of RTF+ CD38(+) (P < 0.0001) or RTF+ HLA-DR+ (P = 0.0001) CD4(+) T cells than HIV- individuals. In HIV+ individuals, increased percentages of CD4(+) T cells that were RTF+, RTF+ CD38(+), and RTF+ HLA-DR+ correlated inversely with the absolute number and percentage of CD4(+) T cells and correlated positively with plasma beta(2)-microglobulin concentrations. HIV+ individuals had higher percentages of CD8(+) T cells that were RTF+ CD38(+) (P = 0.0001) or RTF+ HLA-DR+ (P = 0.0010). In HIV+ individuals, increased percentages of CD8(+) T tells that were RTF+ HLA-DR+ correlated inversely with the percentage of CD4(+) T cells, and high percentages of CD8(+) T cells that were RTF+ CD38(+) correlated positively with plasma beta(2)-microglobulin levels. These findings strongly suggest that increased RTP expression is a correlate of HIV-associated immune system activation.